HIKAL
|
The Current P/S Ratio of HIKAL is 1.65.
| Share Price | ₹227.7 | Dec 30,2025 |
| Market Cap | ₹2,806.9 Cr | |
| Sales-TTM | ₹1,699.0 Cr | TTM-Consolidated Results |
| Price/Sales | 1.65x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of HIKAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,806.9 Cr] as on Dec 30,2025
(/) Sales [ ₹1,699.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.65x ]
Thus, for HIKAL , the investors are currently willing to pay '1.65 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of HIKAL !
The chart below summarizes the trend in P/S Ratio of HIKAL over the last five years.
Historical PS (Price/Sales) ratio chart of HIKAL
PS Ratio Performance Analysis for HIKAL
- HIKAL 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.96x.
- HIKAL 's operated at median p/e ratio of 1.83x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/e ratio peaked in Mar2025 at 2.66x.
- HIKAL 's p/e ratio hit its five-year low in Mar2021 of 1.03x.
How does HIKAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| HIKAL | 1,699.0 | 1.65 | 2,806.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.51 | 412,590.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.01 | 170,577.0 |
| CIPLA LTD | 28,349.6 | 4.25 | 120,471.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.56 | 129,301.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.08 | 105,660.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.55 | 88,885.2 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.70 | 90,691.9 |
| LUPIN LTD | 24,750.7 | 3.84 | 95,059.8 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.12 | 68,952.8 |
| ABBOTT INDIA LTD | 6,714.4 | 9.02 | 60,580.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs HIKAL 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.65x |
| Max industry PS | 17.01x |
| Median industry PS | 4.25x |
| Average industry PS | 6.30x |
You may also like the below Video Courses